Загрузка...
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS
BACKGROUND: UNAIDS estimates that 34 million people are currently living with the human immunodeficiency virus (HIV) worldwide. Currently recommended regimens for initiating HIV treatment consist of either a non‐nucleoside reverse transcriptase inhibitor (NNRTI) or ritonavir‐boosted protease inhibit...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2013
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7026626/ https://ncbi.nlm.nih.gov/pubmed/23543540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005481.pub3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|